Sodium-ion, solar, and Wegovy maker: A look at NC’s 5 largest job announcements of 2024
Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.
We’ve Accepted Wegovy and Zepbound. The Next Phase Is Harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
dailymemphian14h
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
Weight-loss drugs are great — but real food still matters | Opinion
Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...
Hosted on MSN1h
American Academy of Pediatrics recommends weight-loss drugs for some younger patients
Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...
24/7 Wall St18h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
tdn8hOpinion
Lisa Jarvis column: The bar for successful obesity drugs is rising
Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...
Alaska Dispatch News2dOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
A Diet Writer’s Regrets
No one has ever known so much about healthy eating and been less successful at following her own advice.